Login / Signup

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.

Vianney TricouBrandon EssinkJohn E ErvinMark TurnerIan EscuderoMartina RauscherManja BroseInge LefevreAstrid BorkowskiDerek Wallace
Published in: PLoS neglected tropical diseases (2023)
ClinicalTrials.gov identified: NCT03342898.
Keyphrases
  • zika virus
  • double blind
  • open label
  • placebo controlled
  • dengue virus
  • aedes aegypti
  • phase ii
  • clinical trial
  • randomized controlled trial